MAG3 Trademark

Trademark Overview

On Thursday, November 8, 2018, a trademark application was filed for MAG3 with the United States Patent and Trademark Office. The USPTO has given the MAG3 trademark a serial number of 88186404. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, November 14, 2025. This trademark is owned by Mallinckrodt Nuclear Medicine LLC. The MAG3 trademark is filed in the Pharmaceutical Products category with the following description:

Medical kit comprised of reaction vials pre-filled with diagnostic radiopharmaceutical preparations and instruction insert for the preparation of a diagnostic radiopharmaceutical for determining renal function
mag3

General Information

Serial Number88186404
Word MarkMAG3
Filing DateThursday, November 8, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, November 14, 2025
Registration Number6088223
Registration DateTuesday, June 30, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 14, 2020

Trademark Statements

Goods and ServicesMedical kit comprised of reaction vials pre-filled with diagnostic radiopharmaceutical preparations and instruction insert for the preparation of a diagnostic radiopharmaceutical for determining renal function

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 27, 2018
Primary Code005
First Use Anywhere DateSaturday, October 31, 1998
First Use In Commerce DateSaturday, October 31, 1998

Trademark Owner History

Party NameCURIUM US LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressST. LOUIS, MO 63146
Party NameCURIUM US LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressST. LOUIS, MO 63146
Party NameCURIUM US LLC
Party Type11 - New Owner Before Publication
Legal Entity Type16 - Limited Liability Company
AddressST. LOUIS, MO 63146
Party NameMallinckrodt Nuclear Medicine LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSt. Louis, MO 63146

Trademark Events

Event DateEvent Description
Monday, November 12, 2018NEW APPLICATION ENTERED
Tuesday, November 27, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 2, 2019ASSIGNED TO EXAMINER
Tuesday, January 8, 2019NON-FINAL ACTION WRITTEN
Tuesday, January 8, 2019NON-FINAL ACTION E-MAILED
Tuesday, January 8, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 5, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 11, 2019ASSIGNED TO LIE
Monday, July 15, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 15, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 6, 2019NON-FINAL ACTION WRITTEN
Tuesday, August 6, 2019NON-FINAL ACTION E-MAILED
Tuesday, August 6, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 5, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 5, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 5, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 26, 2020NON-FINAL ACTION WRITTEN
Wednesday, February 26, 2020NON-FINAL ACTION E-MAILED
Wednesday, February 26, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 26, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, March 2, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 2, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 2, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, March 7, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 25, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 14, 2020PUBLISHED FOR OPPOSITION
Tuesday, April 14, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 30, 2020REGISTERED-PRINCIPAL REGISTER
Monday, June 30, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, July 28, 2025TEAS SECTION 8 & 15 RECEIVED
Friday, November 14, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, November 14, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, November 14, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

diagnostic radiopharmaceutical preparation insert determining renal function instruction preparations vials